Why Integra Lifesciences Stock Is Sinking Today
Shares of Integra Lifesciences (NASDAQ: IART) were sinking 15.5% as of 11 a.m. ET on Monday. The decline came after the medical technology company announced its second-quarter results before the market opened.
Integra reported Q2 revenue of $418.2 million, up 9.7% year over year. This topped the average analyst revenue estimate of nearly $413.2 million.
The company posted a loss per share of $0.16, based on generally accepted accounting principles (GAAP). Integra announced adjusted earnings per share (EPS) of $0.63. Although this reflected a decline from adjusted EPS of $0.71 in the prior-year period, it narrowly beat the consensus estimate of $0.62.
Source Fool.com
Integra LifeSciences Holdings Corp Stock
€23.00
-20.690%
With 3 Buy predictions and 4 Sell predictions the community is currently undecided on Integra LifeSciences Holdings Corp.
On the other hand, the target price of 24 € is above the current price of 23.0 € for Integra LifeSciences Holdings Corp, so the potential is actually 4.35%.
